drugset / Trial / NCT00248118

Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking

NCT00248118

Phase 2/3 Terminated 72 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine: 1) the short-term clinical efficacy and safety of bupropion for helping adolescent tobacco smokers quit, and 2) The role of withdrawal symptoms in the maintenance of smoking in adolescents.

Timeline

Start
2005-01
Primary completion
2007-08
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupropion Small molecule 300 mg

Indications